abstract |
Disclosed is a thrombin receptor antagonist of structural formula (I) wherein the substituents are as defined in the specification. Compounds of the type disclosed are useful for the treatment of thrombotic, inflammatory, artherosclerotic or fibroproliferative disorders. |